stockrowProKidney Corp. (PROK) vs X4 Pharmaceuticals, Inc. (XFOR)
- ProKidney Corp. PROK 1.15 +7.48%
- X4 Pharmaceuticals, Inc. XFOR 3.15 +2.61%
ProKidney Corp. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. ProKidney Corp. and X4 Pharmaceuticals, Inc. are of similar size ($322.0M and $304.4M). X4 Pharmaceuticals, Inc. has the higher net margin (−474.7% vs −10,288.4%) and the lower return on invested capital (−178.2% vs 0.00%). Across the 15 metrics below, X4 Pharmaceuticals, Inc. leads on 9 and ProKidney Corp. on 6.
Valuation
Profitability
| Metric | PROK | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 81.77% | 68.51% |
| Operating margin | (21,664.55%) | (473.95%) | 0.00% |
| Net margin | (10,288.39%) | (474.74%) | 0.00% |
| Free cash flow margin | (17,300.61%) | (478.16%) | 0.00% |
| Return on equity | 8.92% | (80.32%) | (51.96%) |
| Return on assets | (27.10%) | (40.73%) | (46.06%) |
| Return on invested capital | 0.00% | (178.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack